Evidence map›Paper›PMID 40448146›Full record

ArticleJournal of neuroinflammation2025

Astrocyte-derived extracellular vesicular NFIA mediates obesity-associated cognitive impairment.

Lining Wu, Liyun Deng, Xiaolin Xu, Haiqing Chang, Changliang Liu, Jiahui Wu, Changteng Zhang, Ruiqun Wang, Rui Gao, Hai Chen and 4 more

Abstract read
In one paragraph

Article in Journal of neuroinflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Effects of obesity on brain health and cognition.Nature reviews. Neurology · 2026
    Review
  2. Article
  3. Article
  4. Extracellular RNAs as Messengers and Early Biomarkers in Neurodegeneration.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lining Wu *Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China.
Liyun Deng *Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China.
Xiaolin XuDepartment of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China.
Haiqing ChangDepartment of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China.
Changliang LiuDepartment of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China.
Jiahui WuDepartment of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China.
Changteng ZhangDepartment of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China.
Ruiqun WangDepartment of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China.
Rui GaoDepartment of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China.
Hai ChenDepartment of Respiratory and Critical Care Medicine, Targeted Tracer Research and Development Laboratory, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China.
Shixin Ye-LehmannDiseases and Hormones of the Nervous System, Unité INSERM U1195, University of Paris-Scalay, Bicêtre Hosptial, Bât. Grégory Pincus, Le Kremlin-Bicêtre, France.
Zhi ZhangDepartment of Anesthesiology, The First Affiliated Hospital of University of Science and Technology of China, Hefei National Laboratory for Physical Sciences at the Microscale, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, P.R. China.
Tao ZhuDepartment of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China. xwtao.zhu@foxmail.com.
Chan ChenDepartment of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China. xychenchan@gmail.com.

Funding

National Natural Science Foundation of China No. 82171185the Central Guidance on Local Science and Technology Development Fund of Sichuan Province No.23ZYZYTS0135
6 · The paper itself

Abstract

backgroundThe escalating global prevalence of cognitive decline associated with obesity represents a significant public health challenge. Emerging evidence implicates astrocyte-derived extracellular vesicles (ADEVs) as key mediators in the pathogenesis of neurodegenerative disease, positioning them as potential therapeutic targets. However, the precise mechanistic role of ADEVs in the pathological processes underlying obesity-related cognitive impairment remains poorly understood.

methodsWe established an obese mouse model by feeding mice a 60% high-fat diet (HFD) and assessed cognitive function through a series of behavioral tests. To investigate the role of extracellular vesicles (EVs), we inhibited EVs secretion by intraperitoneally administering GW4869, a neutral sphingomyelinase-2 (nSMase2) inhibitor, to 12-week HFD-fed male mice. Using comprehensive proteomic sequencing of brain-derived EVs, we identified NFIA as a potentially candidate protein. A series of in vivo and in vitro experiments were then conducted to confirmed the astrocytic origin of NFIA and neuronal uptake of ADEVs. Further, ADEVs isolated from primary cultured astrocytes under high glucose conditions were administered to both wild-type mice and primary cultured neurons to demonstrate their mediating role. Additionally, we developed adeno-associated virus (AAV) constructs to specifically knockdown the target gene Nfia of astrocyte to validate these findings.

resultsFollowing 16 weeks of HFD feeding, obese mice exhibited significant cognitive impairment, which was significantly alleviated by GW4869 administration through inhibition of ceramide-dependent EVs secretion. Proteomic analysis revealed a marked upregulation of NFIA protein in brain-derived EVs from obese mice, with astrocytes identified as the predominant cellular origin. ADEVs containing NFIA has been found to specifically accumulated in the hippocampal neurons both in vivo and in vitro. As expected, ADEVs isolated from high glucose-treated primary astrocytes induced substantial cognitive decline in healthy adult mice and caused synaptic injury in primary cultured neurons. Of note, astrocyte-specific knockdown of the Nfia gene resulted in improved synaptic function and ameliorated cognitive impairment in obese mice.

conclusionsThese findings demonstrated that elevated levels of NFIA packaged within ADEVs contributed to hippocampal synaptic injury under obesity-induced stress condition. The mechanistic insight may provide potential therapeutic targets for addressing obesity-related cognitive decline.

Indexed as

AstrocytesCognitive DysfunctionExtracellular VesiclesObesityAnimalsCells, CulturedDiet, High-FatMaleMiceMice, Inbred C57BLAstrocytesCognitive impairmentExtracellular vesiclesNFIAObesitySynaptic injury

Identifiers

PMID40448146
PMCPMC12125936

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.